NCT01042210

Brief Summary

The study is focused on the investigation of possible associations between plasma/serum levels of agouti related peptide (AgRP) and its genetic background in healthy women with physiological pregnancy (non-preeclamptic) and women with preeclampsia, in the postpartum period, and in their offspring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2006

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2010

Completed
Last Updated

January 5, 2010

Status Verified

November 1, 2009

Enrollment Period

1.2 years

First QC Date

January 4, 2010

Last Update Submit

January 4, 2010

Conditions

Keywords

preeclampsiaagouti-related peptideintrauterine growthbirth weightIntrauterine growth restriction due to preeclampsia

Outcome Measures

Primary Outcomes (2)

  • plasma/serum level of agouti/related peptide in peripheral blood in postpartum mother

    2-4 hours postpartum

  • Plasma level of agouti-related peptide in umbilical cord blood from the newborn

    immediately postpartum

Secondary Outcomes (3)

  • maternal weight gain during pregnancy

    using postpartum and peripartum data

  • birth weight of the newborn

    immediately postpartum

  • maternal preconceptional BMI

    anamnestic information

Study Arms (4)

Mothers, preeclampsia

Mothers with preeclampsia diagnosed according to the Guidelines by the Czech Society of obstetrics and gynecology as development of hypertension after the 20th week of pregnancy (systolic blood pressure, ≥140 mmHg; and/or diastolic blood pressure, ≥90 mmHg; measured at rest on two consecutive occasions at least 24 h apart) in previously normotensive women, and the onset of proteinuria (\>300 mg of urinary protein/L over 24 h).

Newborns, physiological pregnancy-delivery

The newborns from the physiological pregnancies with spontaneous, uncomplicated delivery.

Newborns, pregnancy with preeclampsia

Newborns from the pregnancies complicated by preeclampsia.

Mothers, Physiological pregnancy-labour

The cohort of non-preeclamptic mothers with physiological, uncomplicated conception, pregnancy and delivery.

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients of the Masaryk university afilliated hospital, Clinic of Obstetrics and Gynecology,hospitalized due to preeclampsia or healthy women with uncomplicated conception, pregnancy and delivery that came to give birth at the Clinic. Along with the mothers, their offspring in included in the study. The study population originated from a static region of the Czech Republic - South Moravia.

You may qualify if:

  • For preeclampsia:
  • development of hypertension after the 20th week of pregnancy (systolic blood pressure, ≥140 mmHg; and/or diastolic blood pressure, ≥90 mmHg; measured at rest on two consecutive occasions at least 24 h apart) in previously normotensive women, and the onset of proteinuria (\>300 mg of urinary protein/L over 24 h)
  • single-fetus pregnancy
  • age range 18-35 y
  • no preconceptional history of hypertension
  • For mother with physiological pregnancies:
  • uncomplicated
  • spontaneous conception
  • single-fetus pregnancy
  • age range 18-35 y
  • spontaneous uncomplicated delivery
  • no history of preconceptional hypertension

You may not qualify if:

  • For preeclampsia:
  • multiple pregnancy
  • preeclampsia superimposed to chronic hypertension preceding pregnancy
  • kidney disease
  • fetal malformations
  • For mothers with physiological pregnancies:
  • in vitro fertilization
  • fetal malformations
  • multiple pregnancy
  • events of bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Masaryk university affiliated hospital, Clinic of Obstetrics and Gynecology

Brno, Moravia, 625 00, Czechia

Location

Related Publications (4)

  • Wagner CG, McMahon CD, Marks DL, Daniel JA, Steele B, Sartin JL. A role for agouti-related protein in appetite regulation in a species with continuous nutrient delivery. Neuroendocrinology. 2004;80(4):210-8. doi: 10.1159/000082735. Epub 2004 Dec 13.

    PMID: 15604600BACKGROUND
  • Tamura H, Kamegai J, Shimizu T, Ishii S, Sugihara H, Oikawa S. The effect of agouti-related protein on growth hormone secretion in adult male rats. Regul Pept. 2005 Feb 15;125(1-3):145-9. doi: 10.1016/j.regpep.2004.08.012.

    PMID: 15582725BACKGROUND
  • Gavrila A, Chan JL, Miller LC, Heist K, Yiannakouris N, Mantzoros CS. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration. J Clin Endocrinol Metab. 2005 Feb;90(2):1047-54. doi: 10.1210/jc.2004-1124. Epub 2004 Nov 16.

    PMID: 15546902BACKGROUND
  • Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf). 2004 Jul;61(1):31-9. doi: 10.1111/j.1365-2265.2004.02056.x.

    PMID: 15212642BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, umbilical blood

MeSH Terms

Conditions

Pre-EclampsiaBirth Weight

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Julie Bienertova-Vasku, MD.,, Ph.D.

    Department of Pathological Physiology, Faculty of Medicine, Masaryk University

    PRINCIPAL INVESTIGATOR
  • Anna Vasku, prof. Ph.D.

    Department of Pathological Physiology, Faculty of Medicine, Masaryk University

    STUDY DIRECTOR
  • Petr Bienert, Dr.

    Department of Pathological Physiology, Faculty of Medicine, Masaryk University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 4, 2010

First Posted

January 5, 2010

Study Start

January 1, 2005

Primary Completion

March 1, 2006

Study Completion

December 1, 2006

Last Updated

January 5, 2010

Record last verified: 2009-11

Locations